Page 330 - Read Online
P. 330

Varikuti et al. Vessel Plus 2020;4:28  I  http://dx.doi.org/10.20517/2574-1209.2020.27                                               Page 9 of 20
                                                                        [79]
               mediates the adhesion of mononuclear cells to the endothelial cells . Both human and animal leishmanial
               infections lead to increased levels of vascular endothelial growth factor-A (VEGF-A) and its receptor
               (VEGF-R) in the skin [80,81] . Recently, Weinkopff et al. [133]  showed that CL infection by L. major induces
               VEGF-A in macrophages in an ARNT/HIF dependent manner, leading to the limitation of inflammation
               and lymphangiogenesis. The expansion of the lymphatic network promotes lesion resolution, and inhibition
               of this process enhances the lesion development. In the VL model, L. donovani-infected mice aberrantly
               express neurotrophic tyrosine kinase receptor type-2 (Ntrk2) on splenic endothelial cells, which plays a role
                                                [82]
               in pathologic remodeling of the spleen .

               Role of exosomes in leishmaniasis
               The role of exosomes in Leishmania infection is well studied, revealing that they serve as a key mode
               of delivery of Leishmania virulence factors and effector proteins to host cells during infection [136] . Both
               pathogen and host-derived exosomes have been identified in this process. Leishmania-derived exosomes
               can transport virulence factors into the host macrophages and induce secretion of IL-8 instead of
               TNF-β [105] . Proteomic analysis has revealed that one such virulence factor contained in L. major exosomes
               is the metalloprotease glycoprotein GP63, which regulates protein tyrosine phosphatases (PTPs) and
               transcription factors (TFs), such as NF-kB, in target macrophages [108] . PTPs prevent macrophage activation
               by inhibiting the secretion of pro-inflammatory IFN-g, IL-12, and NO [137,138] , which are important in host
               control of parasite infection. These act to modulate the immune response, diminishing inflammation in
               favor of parasite growth and survival. Exosomes released from L. donovani-infected macrophages contain
               GP63, which proteolyzes Dicer1 in hepatocytes to block miRNA-122, production leading to disease
               progression [109] . Exosomes released from L. donovani promastigotes can effectively alter the cytokine
               response of monocytes through the upregulation of IL-10 and inhibition of TNF-a production. Similarly, it
               has been observed that monocyte-derived DCs that have been exposed to parasite exosomes have inhibited
               levels of IL-12p70, TNF-a, and IL-10. Exosome-exposed DCs cannot induce naïve T cell differentiation
               into mature Th1 cells [106] . In contrast, Schnitzer et al. [110]  showed that that vaccination with L. major antigens
               present in DC-derived exosomes can induce immune-protection against the infection.


               Leishmania is also able to modify the production and content of exosomes in response to environmental
               stress (heat shock and pH) that mimic infection. Silverman et al. [105]  showed that vesicle release from
               parasites can be increased by three-fold in response to heat shock. Interestingly, Atayde et al. [107]  showed
               that Leishmania release exosomes within the lumen of the sand-fly midgut, which are ejected in the
               egested inoculum during by the sand-fly bite. These exosomes lead to exacerbated lesions in L. major
               and L. infantum models, possibly due to increased production of inflammatory cytokine IL-17a, and
               overproduction of IL-4 and IL-10, which are both known to suppress the Th1 responses and play a role in
               disease susceptibility.

               TOXOPLASMOSIS
               Toxoplasmosis is caused by the obligate intracellular protozoan parasite, Toxoplasma gondii, which
               infects healthy and immunocompromised individuals worldwide. It is estimated that more than 11% of
               the population in the US and 60% of the population throughout the world are infected [139]  (https://www.
               cdc.gov/parasites/toxoplasmosis/epi.html). The transmission of toxoplasmosis mainly occurs through
               ingesting raw meat containing T. gondii cysts (foodborne) or water containing oocysts from feline feces
               (waterborne). The parasite can also be transmitted congenitally when a woman acquires the infection
               during pregnancy [139] , or very rarely through transplantation of organs [140] . Although felines act as definitive
               hosts for T. gondii, it can infect almost all nucleated mammalian and avian cells. The life cycle of T. gondii
               mainly involves an asexual phase within nucleated cells and a sexual phase, which occurs in felines.
               Ingested oocysts released in feline feces serve as the infectious stage for humans. Toxoplasmosis can
               cause miscarriage, stillborn infants, or severe central nervous system (CNS) disease; in adults, it can lead
   325   326   327   328   329   330   331   332   333   334   335